Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: A multicentre studyHuan Lin, Zaiyi Liu, Mingwei Chen et al.|Cancer Letters|2025Cited by 24
LBA2 | ZANUBRUTINIB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS R‐miniCHOP IN UNFIT OR FRAIL PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA AGED 70 YEARS OR OLDERPeng Xu, Zhenwei Shi, Fei Li et al.|Hematological Oncology|2025Cited by 2